RAPID NUTRITION PLC (ALRPD.PA)
GB00BM9PTW47 - Common Stock
ALRPD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 57 industry peers in the Food Products industry. ALRPD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALRPD does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year ALRPD has reported negative net income.
ALRPD had a negative operating cash flow in the past year.
In multiple years ALRPD reported negative net income over the last 5 years.
ALRPD had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ALRPD has a Return On Assets of -287.36%. This is amonst the worse of the industry: ALRPD underperforms 98.18% of its industry peers.
ALRPD has a worse Return On Equity (-414.45%) than 94.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -287.36% | ||
| ROE | -414.45% | ||
| ROIC | N/A |
ROA(3y)-203.72%
ROA(5y)-165.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ALRPD's Gross Margin of 29.29% is on the low side compared to the rest of the industry. ALRPD is outperformed by 69.09% of its industry peers.
ALRPD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALRPD so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.29% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.3%
GM growth 5Y-25.51%
2. Health
2.1 Basic Checks
The number of shares outstanding for ALRPD has been increased compared to 1 year ago.
ALRPD has more shares outstanding than it did 5 years ago.
ALRPD has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -30.28, we must say that ALRPD is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -30.28, ALRPD is not doing good in the industry: 96.36% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.10 indicates that ALRPD is not too dependend on debt financing.
ALRPD has a better Debt to Equity ratio (0.10) than 92.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -30.28 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 3.49 indicates that ALRPD has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.49, ALRPD belongs to the best of the industry, outperforming 92.73% of the companies in the same industry.
A Quick Ratio of 2.75 indicates that ALRPD has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.75, ALRPD belongs to the top of the industry, outperforming 96.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.49 | ||
| Quick Ratio | 2.75 |
3. Growth
3.1 Past
ALRPD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -158.70%.
The Revenue for ALRPD has decreased by -43.89% in the past year. This is quite bad
ALRPD shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.78% yearly.
EPS 1Y (TTM)-158.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-43.89%
Revenue growth 3Y-23.38%
Revenue growth 5Y-16.78%
Sales Q2Q%4.62%
3.2 Future
Based on estimates for the next years, ALRPD will show a very negative growth in Earnings Per Share. The EPS will decrease by -55.42% on average per year.
Based on estimates for the next years, ALRPD will show a decrease in Revenue. The Revenue will decrease by -9.59% on average per year.
EPS Next Y-100%
EPS Next 2Y-41.42%
EPS Next 3Y-25.99%
EPS Next 5Y-55.42%
Revenue Next Year-50.1%
Revenue Next 2Y-26.78%
Revenue Next 3Y-15.84%
Revenue Next 5Y-9.59%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as ALRPD's earnings are expected to decrease with -25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.42%
EPS Next 3Y-25.99%
5. Dividend
5.1 Amount
ALRPD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
RAPID NUTRITION PLC
EPA:ALRPD (1/3/2025, 7:00:00 PM)
0.04
0 (-5.66%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.90M
Analysts84.44
Price Target0.51 (1175%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.98 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.58 | ||
| P/tB | 5.2 | ||
| EV/EBITDA | N/A |
EPS(TTM)0
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.01
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -287.36% | ||
| ROE | -414.45% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.29% | ||
| FCFM | N/A |
ROA(3y)-203.72%
ROA(5y)-165.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.3%
GM growth 5Y-25.51%
F-Score3
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.49 | ||
| Quick Ratio | 2.75 | ||
| Altman-Z | -30.28 |
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-158.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-100%
EPS Next 2Y-41.42%
EPS Next 3Y-25.99%
EPS Next 5Y-55.42%
Revenue 1Y (TTM)-43.89%
Revenue growth 3Y-23.38%
Revenue growth 5Y-16.78%
Sales Q2Q%4.62%
Revenue Next Year-50.1%
Revenue Next 2Y-26.78%
Revenue Next 3Y-15.84%
Revenue Next 5Y-9.59%
EBIT growth 1Y-364.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-12.16%
EBIT Next 3Y-39.34%
EBIT Next 5Y-27.07%
FCF growth 1Y-659.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-659.99%
OCF growth 3YN/A
OCF growth 5YN/A